TipRanks
Advertisement
Advertisement
Krystal Biotech Earnings Call Signals Profitable Growth
PremiumCompany AnnouncementsKrystal Biotech Earnings Call Signals Profitable Growth
2M ago
Alec Stranahan Maintains Buy on Krystal Biotech, Slightly Lowers Price Target to $392 Amid Strong Vyjuvek Momentum and Pipeline Catalysts
Premium
Ratings
Alec Stranahan Maintains Buy on Krystal Biotech, Slightly Lowers Price Target to $392 Amid Strong Vyjuvek Momentum and Pipeline Catalysts
2M ago
Krystal Biotech price target lowered to $392 from $396 at BofA
Premium
The Fly
Krystal Biotech price target lowered to $392 from $396 at BofA
2M ago
KRYS Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsKRYS Upcoming Earnings Report: What to Expect?
2M ago
Krystal Biotech Updates KB801 Patent Office Filing
Premium
Company Announcements
Krystal Biotech Updates KB801 Patent Office Filing
3M ago
Krystal Biotech to replace Taylor Morrison in S&P 400 at open on 7/24
Premium
The Fly
Krystal Biotech to replace Taylor Morrison in S&P 400 at open on 7/24
3M ago
Krystal Biotech price target raised to $361 from $310 at H.C. Wainwright
PremiumThe FlyKrystal Biotech price target raised to $361 from $310 at H.C. Wainwright
4M ago
Krystal Biotech Shareholders Approve Directors and Compensation
Premium
Company Announcements
Krystal Biotech Shareholders Approve Directors and Compensation
5M ago
Analyst Reiterates Buy on Krystal Biotech as Vyjuvek Global Launch and Growing Rare-Disease Pipeline Underpin Long-Term Upside
Premium
Ratings
Analyst Reiterates Buy on Krystal Biotech as Vyjuvek Global Launch and Growing Rare-Disease Pipeline Underpin Long-Term Upside
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―